149 related articles for article (PubMed ID: 35173486)
1. Male Breast Carcinoma Metastatic to the Choroid: A Case Report and Opinions of Management.
Fu W; Zheng S; Zhou J; Lu K; Lu Y; Guo G
Cancer Manag Res; 2022; 14():525-534. PubMed ID: 35173486
[TBL] [Abstract][Full Text] [Related]
2. Regression of choroidal metastasis from breast carcinoma with palbociclib.
Parakh S; Das S; Maheshwari S; Gupta V; Luthra G; Luthra S
Int J Retina Vitreous; 2022 Aug; 8(1):54. PubMed ID: 35962417
[TBL] [Abstract][Full Text] [Related]
3. Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial.
Cristofanilli M; Turner NC; Bondarenko I; Ro J; Im SA; Masuda N; Colleoni M; DeMichele A; Loi S; Verma S; Iwata H; Harbeck N; Zhang K; Theall KP; Jiang Y; Bartlett CH; Koehler M; Slamon D
Lancet Oncol; 2016 Apr; 17(4):425-439. PubMed ID: 26947331
[TBL] [Abstract][Full Text] [Related]
4. Unusual Case of Papillary Thyroid Carcinoma with Choroidal Metastasis.
Makhija C; Su YB; Goldner W
Thyroid; 2015 Jul; 25(7):860-4. PubMed ID: 25872533
[TBL] [Abstract][Full Text] [Related]
5. Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial.
Park YH; Kim TY; Kim GM; Kang SY; Park IH; Kim JH; Lee KE; Ahn HK; Lee MH; Kim HJ; Kim HJ; Lee JI; Koh SJ; Kim JY; Lee KH; Sohn J; Kim SB; Ahn JS; Im YH; Jung KH; Im SA;
Lancet Oncol; 2019 Dec; 20(12):1750-1759. PubMed ID: 31668850
[TBL] [Abstract][Full Text] [Related]
6. [Successful Treatment of Estrogen Receptor Positive, HER2 Negative Breast Cancer with Life-Threatening Multiple Bone Metastases Using the Combination of Fulvestrant and Palbociclib-A Case Report].
Nakamura A; Shigekawa T; Asakawa H; Park K; Baba N
Gan To Kagaku Ryoho; 2021 Oct; 48(10):1251-1254. PubMed ID: 34657057
[TBL] [Abstract][Full Text] [Related]
7. CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis.
Gao JJ; Cheng J; Bloomquist E; Sanchez J; Wedam SB; Singh H; Amiri-Kordestani L; Ibrahim A; Sridhara R; Goldberg KB; Theoret MR; Kluetz PG; Blumenthal GM; Pazdur R; Beaver JA; Prowell TM
Lancet Oncol; 2020 Feb; 21(2):250-260. PubMed ID: 31859246
[TBL] [Abstract][Full Text] [Related]
8. Metastases to extraocular muscles from breast cancer: case report and up-to-date review of the literature.
Framarino-Dei-Malatesta M; Chiarito A; Bianciardi F; Fiorelli M; Ligato A; Naso G; Pecorella I
BMC Cancer; 2019 Jan; 19(1):36. PubMed ID: 30621656
[TBL] [Abstract][Full Text] [Related]
9. Potential role of significant GATA3 mutation in male breast cancer responding to endocrine therapy: A case report.
Xia Y; Liu X; Li W; Zhu Y
Indian J Pathol Microbiol; 2021; 64(1):161-164. PubMed ID: 33433431
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer: Patient-reported outcomes in the PEARL study.
Kahan Z; Gil-Gil M; Ruiz-Borrego M; Carrasco E; Ciruelos E; Muñoz M; Bermejo B; Margeli M; Antón A; Casas M; Csöszi T; Murillo L; Morales S; Calvo L; Lang I; Alba E; de la Haba-Rodriguez J; Ramos M; López IÁ; Gal-Yam E; Garcia-Palomo A; Alvarez E; González-Santiago S; Rodríguez CA; Servitja S; Corsaro M; Rodrigálvarez G; Zielinski C; Martín M
Eur J Cancer; 2021 Oct; 156():70-82. PubMed ID: 34425406
[TBL] [Abstract][Full Text] [Related]
11. Choroidal metastasis from carcinoma of breast detected on F18-FDG PET CT scan: A case report and review of literature.
Solav S; Bhandari R; Sowani A; Saxena S
Indian J Nucl Med; 2010 Oct; 25(4):160-3. PubMed ID: 21713225
[TBL] [Abstract][Full Text] [Related]
12. Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.
Giuliano M; Schettini F; Rognoni C; Milani M; Jerusalem G; Bachelot T; De Laurentiis M; Thomas G; De Placido P; Arpino G; De Placido S; Cristofanilli M; Giordano A; Puglisi F; Pistilli B; Prat A; Del Mastro L; Venturini S; Generali D
Lancet Oncol; 2019 Oct; 20(10):1360-1369. PubMed ID: 31494037
[TBL] [Abstract][Full Text] [Related]
13. Choroidal metastasis as a presenting manifestation of lung cancer: a report of 3 cases and systematic review of the literature.
Singh N; Kulkarni P; Aggarwal AN; Mittal BR; Gupta N; Behera D; Gupta A
Medicine (Baltimore); 2012 Jul; 91(4):179-194. PubMed ID: 22732948
[TBL] [Abstract][Full Text] [Related]
14. Choroidal metastasis of pancreatic adenocarcinoma: case report.
Shriram J; Stoltz R; Borazanci E
AME Case Rep; 2024; 8():22. PubMed ID: 38234350
[TBL] [Abstract][Full Text] [Related]
15. Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer.
Lainé M; Fanning SW; Chang YF; Green B; Greene ME; Komm B; Kurleto JD; Phung L; Greene GL
Breast Cancer Res; 2021 May; 23(1):54. PubMed ID: 33980285
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Palbociclib and Fulvestrant in Japanese Patients With ER+/HER2- Advanced/Metastatic Breast Cancer.
Seki H; Sakurai T; Maeda Y; Oki N; Aoyama M; Yamaguchi R; Tokuda T; Kaburagi T; Okumura T; Karahashi T; Nakajima K; Higeta K; Shimizu K
In Vivo; 2019; 33(6):2037-2044. PubMed ID: 31662535
[TBL] [Abstract][Full Text] [Related]
17. [18F]-Fluorodeoxyglucose Positron Emission Tomography/CT to Assess the Early Metabolic Response in Patients with Hormone Receptor-Positive HER2-Negative Metastasized Breast Cancer Treated with Cyclin-Dependent 4/6 Kinase Inhibitors.
Seifert R; Küper A; Tewes M; Heuschmid M; Welt A; Fendler WP; Herrmann K; Decker T
Oncol Res Treat; 2021; 44(7-8):400-407. PubMed ID: 34102639
[TBL] [Abstract][Full Text] [Related]
18. Plasma thymidine kinase 1 activity and outcome of ER+ HER2- metastatic breast cancer patients treated with palbociclib and endocrine therapy.
Cabel L; Rosenblum D; Lerebours F; Brain E; Loirat D; Bergqvist M; Cottu P; Donnadieu A; Bethune A; Kiavue N; Rodrigues M; Pierga JY; Tanguy ML; Bidard FC
Breast Cancer Res; 2020 Sep; 22(1):98. PubMed ID: 32928264
[TBL] [Abstract][Full Text] [Related]
19. Rare metastasis in a patient with BRAF-mutated rectal cancer: choroidal metastasis - case report and literature review.
Demir H; Ekim MM; Özgül E; Davarci SE; Baykara M
GMS Ophthalmol Cases; 2024; 14():Doc03. PubMed ID: 38774401
[TBL] [Abstract][Full Text] [Related]
20. [Combination Therapy of Bevacizumab plus Paclitaxel Was Effective for a Metastatic Choroidal Tumor Secondary to Breast Cancer in a Patient with Ocular Symptoms].
Hattori M; Shirahane K; Sakai M; Sassa Y; Nishihara Y; Aibe H; Masuda M; Mori D
Gan To Kagaku Ryoho; 2020 Aug; 47(8):1221-1224. PubMed ID: 32829359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
